Metabolic Therapy of Malignant Gliomas

  • James T. Robertson
  • E. Stanfield Rogers
  • W. L. Banks
  • Harold F. Young
Part of the Cancer Treatment and Research book series (CTAR, volume 12)

Abstract

Malignant gliomas, in particularly glioblastoma multiforme, comprise 50% of all primary intracranial tumors affecting the cerebral hemispheres in adults [1]. These dreadful neoplasms have resisted all attempts at permanent cure by combinations of surgery, radiation therapy and chemotherapy. Of the malignant gliomas, clearly, the anaplastic astrocytoma Grade 3 and 4 (glioblastoma multiforme) have universally fatal outcomes. Surgical resection is limited to gross tumor removal to insure adequate decompression of the brain and, although some studies suggest extensive decompressions are followed by longer term survivals, tumor location within the brain prevents radical surgery as employed for cancer elsewhere.

Keywords

Adenocarcinoma Sarcoma Arginine Neurol Sponge 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wilson CB, Boldery EB, Enot KJ: Bis (2-chloroethyl)-l-nitrosourea (NSC-409962) in the treatment of brain tumors. Cancer Chemotherapy Reports 54:p 273–281, 1970.Google Scholar
  2. 2.
    Walker MD, Hunt WE, Mahaley MS, Norrell HA, Ransohoff J, Gehan EA: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:pp 333–343, 1978.PubMedCrossRefGoogle Scholar
  3. 3.
    Kusske JA, Williams JP, Garcia JH, Pribram HW: Radiation necrosis of the brain following radiotherapy of extracerebral neoplasms. Surg Neurol 6:pp 15–20, 1976.PubMedGoogle Scholar
  4. 4.
    Sogg RL, Donaldson SS, Yorke CH: Malignant astrocytoma following radiotherapy of a craniopharyngioma. J Neurosurg 48:pp 622–627, 1978.PubMedCrossRefGoogle Scholar
  5. 5.
    Caveness WF: Pathology of radiation damage to the normal brain of the Monkey. National Cancer Institute Monograph 46:pp 57–76, 1976.Google Scholar
  6. 6.
    Shapiro WR: Management of Primary Malignant Brain Tumors. Neurol Neurosurg Update, Biomedia Inc. Princeton, NJ, 1978.Google Scholar
  7. 7.
    Hologe PY, Jenkins EE, Greenberg SD: Pulmonary Toxicity in Long Term Administration of BCNU. Cancer Treatment Reports 60:pp 1691–1694, 1976.Google Scholar
  8. 8.
    Jones MPH, Marsden HB, Bailey CC: Fatal pulmonary fibrosis following 1,3-Bis (2-chloroethyl)-Nitrosourea (BCNU) therapy. Cancer 42:pp 74–76, 1978.PubMedCrossRefGoogle Scholar
  9. 9.
    Greer CR, Rogers S, Robertson JT, Molinary S, Smith MA, Ramey DR: Specific therapy of patients with malignant brain tumors by using surgery, irradiation, and metabolic control. Clin Cong of the Am Col of Surgeons, abst 843, p 179, San Francisco (October 1975).Google Scholar
  10. 10.
    Tannenbaum A: Relationship of body weight to cancer incidence. Amer J Cancer 38: 335 (1970).Google Scholar
  11. 11.
    White ER, Belkin M: Source of tumor protein. 1. Effect of a low-nitrogen diet on the establishment and growth of a transplanted tumor. J Natl Cancer Inst 5:pp 261–263, 1945.Google Scholar
  12. 12.
    White ER: Source of tumor protein. II. Nitrogen-balance studies of tumor bearing mice fed a low nitrogen diet. J Natl Cancer Inst 5:pp 265–270, 1945.Google Scholar
  13. 13.
    Sherman CD Jr, Morton JJ, Mider GB: Potential sources of tumor nitrogen. Cancer Res 10:pp 374–378, 1950.PubMedGoogle Scholar
  14. 14.
    Babson AL: Some host-tumor relationships with respect to nitrogen. Cancer Res 14:pp 89–93, 1954.PubMedGoogle Scholar
  15. 15.
    Skipper HE, Thomson JR: Amino Acids and Peptides with Antimetabolic Activity. Little Brown and Co, pp 38–53, 1958.Google Scholar
  16. 16.
    Sugimura T, Birnbaum SM, Winitz M, Greenstein JP: Quantitative Nutritional Studies with Water-soluble, Chemically Defined Diets. VII. The forced feeding of diets lacking one essential amino acid. Arch Biochem Biophys 81:pp 448–455, 1959.PubMedCrossRefGoogle Scholar
  17. 17.
    Lorincz AB, Kuttner RE, Brandt MB: Tumor response to PHE-TYR limited diets. J Amer Dietetic Assn 54:pp 198–205, 1969.Google Scholar
  18. 18.
    Demopoulos HB: Effects of low phenylalanine-tyrosine diets on S91 Mouse melanomas. J Natl Cancer Inst 37:pp 185–190, 1966.PubMedGoogle Scholar
  19. 19.
    Pine MJ: Effect of low phenylaline diet on murine leukemia LI210. J Natl Cancer Inst 60:pp 633–641, 1978.PubMedGoogle Scholar
  20. 20.
    Jose DJ, Good RA: Quantitative effects of nutritional essential amino acid deficiency upon immune response to tumors in mice. J Exp Med 137:pp 1–9, 1972.CrossRefGoogle Scholar
  21. 21.
    Rogers S: Induction of Arginase in Rabbit Epithelium by the Shope rabbit papilloma Virus, Nature 183, 1815, 1959.PubMedCrossRefGoogle Scholar
  22. 22.
    Roger S, Moore M: Studies of the mechanism of action of the Shope rabbit papilloma virus. J Exp Med 117: 521, 1963.CrossRefGoogle Scholar
  23. 23.
    Rogers S: Shope papilloma virus: a passenger in man and its significance to the potential control of the host genome. Nature 212: 1220, 1966.PubMedCrossRefGoogle Scholar
  24. 24.
    Rogers S: Significance of dialysis against enzymes to the specific therapy of cancer and genetic deficiency diseases. Nature 220: 1321, 1968.PubMedCrossRefGoogle Scholar
  25. 25.
    Theur RC: Effect of essential amino acid restriction on the growth of female C57BL mice and their implanted BW 10232 adenocarcinomas, J Nutrition 101:pp 223–232, 1971.Google Scholar
  26. 26.
    Worthington BS, Syrotock J A, Ahmed SI: Effects of essential amino acid deficiencies on syngeneic tumor immunity and carcinogenesis in mice. J Nutrition 108:pp 1402–1411, 1978.Google Scholar
  27. 27.
    Lowery SF, Goodgame T, Norton JA, Jones DC, Brennan MF: Effect of chronic protein malnutrition on host-tumor composition and growth. Surgical Research 26:pp 79–86, 1979.CrossRefGoogle Scholar
  28. 28.
    Lowe CU et al: Committee on Nutrition, American Academy of Pediatrics: Nutritional Management in Hereditary Metabolic Disease Ped 40:pp 289–304, 1967.Google Scholar
  29. 29.
    Knox WE: Phenylketonuria. In: The Metabolic Basis of Inherited Disease, Stanbury JB, Wyngaarde JB and Fredrickson DS (eds). McGraw-Hill, NY, pp 226–295, 1972.Google Scholar
  30. 30.
    Edmund J et al: Reduced intake of phenylalanine and tyrosine as treatment of choroidal malignant melanoma. Mod Prob Ophthal 12:pp 504–509, 1974.Google Scholar
  31. 31.
    Lorincz AB, Kuttner RE: Response of malignancy to phenylalanine restriction; a preliminary report on a new concept of managing malignant disease. Nebr State Med J 50:p 609, 1965.PubMedGoogle Scholar
  32. 32.
    Rogers S: Personal communication.Google Scholar
  33. 33.
    Buzzati-Traverso AA: Paper chromatographic pattern of genetically different tissues: A con-tribution to the biochemical study of individuality. Proc Nat Acad Sci 36: 463, 1950.Google Scholar
  34. 34.
    Rogers S, Berton WM: Application of paper chromatography to some of the general problems of pathology. Lab Invest 6: 310, 1957.PubMedGoogle Scholar
  35. 35.
    Rogers S, Woodhall B: Rapid method of metabolically characterizing individual tumors. Proc Soc Exptl Biol Med 98:pp 874–877, 1958.Google Scholar
  36. 36.
    Rogers S, Robertson JT: A method of studying metabolic variation between individual tumors. Nutrition and Cancer, 1981. (In press).Google Scholar
  37. 37.
    Rogers S: Comparative amino acid uptakes of a variety of human tumors and its significance. Nutrition and Cancer, Vol 2 No. 3, p 148, 1981.PubMedCrossRefGoogle Scholar
  38. 38.
    Rogers S, Banks WL Jr, Young HF, Robertson JT et al: Individually tailored dietary restriction therapy and the treatment of malignant gliomas — A status report. Cancer (submitted 1981 ).Google Scholar
  39. 39.
    Rogers S, Woodhall B: Rapid method of metabolically characterizing individual tumors. Proc Soc Exptl Biol and Med 98:pp 874–877, 1958.Google Scholar
  40. 40.
    Rose WC: Amino acid requirement of man. Fed Proc 8:pp 546–552, 1949.PubMedGoogle Scholar
  41. 41.
    Leverton RM, Gram MR, Chaloupka M, Brodousky E, Mitchel A: The quantitative amino acid requirements of young women, I. Threonine. J Nutrition 58:pp 59–81, 1955.Google Scholar
  42. 42.
    National Academy of Sciences: Recommended Dietary Allowances, 8th Edition, Washington DC, p 128, 1974.Google Scholar
  43. 43.
    USDA: Handbook No 8 Revised-Composition of Foods, US Govt Printing Office, Washington DC, p 190, 1963.Google Scholar
  44. 44.
    Burgess JB, Mashburn LT, Robertson JT: Safety of essential amino acid restriction in adults with malignant brain tumors. Nutrition and Cancer, pp 16–21, 1980.Google Scholar
  45. 45.
    Hubner KF, Purvis JT, Mahaley MS Jr, Robertson JT et al: Brain tumor imaging by positron emission computed tomography using 11C-labeled amino acids. Journal of Computer Assisted Tomography 6(3):544–550, June 1982, Raven Press, New York.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers, Boston/The Hague/Dordrecht/Lancaster 1983

Authors and Affiliations

  • James T. Robertson
  • E. Stanfield Rogers
  • W. L. Banks
  • Harold F. Young

There are no affiliations available

Personalised recommendations